Illumina Aktie

111,88 EUR -0,06 EUR -0,05 %

19:20:16

STU

129,88 USD +0,22 USD +0,17 %

19:19:13

BTT

Illumina jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.16,62 Mrd. EUR

Div. Rendite0,00%

WKN927079

ISINUS4523271090

SymbolILMN

Illumina Aktien News

Sortieren:Datum Meistgelesen

12.11.25PR NewswireIllumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study

11.11.25PR NewswireIllumina To Webcast Upcoming Investor Conference

10.11.25PR NewswireIllumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

WerbungIllumina-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

05.11.25PR NewswireIllumina Responds to Positive Updates from Chinese Ministry of Commerce

30.10.25PR NewswireIllumina Reports Financial Results for Third Quarter of Fiscal Year 2025

17.10.25PR NewswireIllumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

16.10.25PR NewswireIllumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

15.10.25PR NewswireIllumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

15.10.25PR NewswireIllumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

14.10.25PR NewswireIllumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025

01.10.25PR NewswireIllumina launches new business to accelerate technology and data-driven discovery

23.09.25PR NewswireIllumina advances personalized cancer care with new pharma development partnerships

18.09.25PR NewswireAlnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine

07.09.25PR NewswireIllumina® Protein Prep bringt neue Erkenntnisse aus der Proteomik für eine verbesserte Arzneimittelforschung und -entwicklung

03.09.25PR NewswireIllumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

19.08.25PR NewswireNilesh Shah joins Illumina as Head of Region, AMEA

30.07.25PR NewswireIllumina enhances flagship assay to accelerate access to comprehensive tumor profiling

10.07.25PR NewswireIllumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025

10.07.25PR NewswireIllumina named to TIME's World's Most Sustainable Companies list for the second consecutive year

25.06.25PR NewswireIllumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

23.06.25PR NewswireIllumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

10.06.25PR Newswirelllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

29.05.25PR NewswireIllumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

28.05.25PR NewswireIllumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies

14.05.25PR NewswireIllumina To Webcast Upcoming Investor Conference

13.05.25PR NewswireIllumina DRAGEN v4.4 powers clinical oncology research and multiomic applications

08.05.25PR NewswireIllumina Reports Financial Results for First Quarter of Fiscal Year 2025

01.05.25PR NewswireIllumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development

15.04.25PR NewswireIllumina and Tempus partner to drive the future of precision medicine through genomic AI innovation

10.04.25PR NewswireIllumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025

25.03.25PR NewswireIllumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors

19.03.25PR NewswireAlliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

06.03.25PR NewswireIllumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year

24.02.25PR NewswireIllumina transforms multiomic research with new technologies to unlock deeper understanding of biology

21.02.25PR NewswireIllumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions

19.02.25PR NewswireIllumina unveils first-of-its-kind spatial transcriptomics technology

18.02.25PR NewswireIllumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference

Illumina News

Illumina News: auf dieser Seite finden Sie alle Illumina News und Nachrichten zur Illumina Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Illumina News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Illumina News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.